Follow The Filings

Farallon Capital Management, L.L.C.

San Francisco, CA 91 processed 13Fs on this site, 2021 Q3 to 2026 Q3

  • $23.2B
  • 108 holdings
  • 2026 Q3
  • +7.1% QoQ
  • Top 5 31.0%

Farallon Capital Management's biggest moves in 2026 Q3 were opening Warner Bros. Discovery and ROKU Inc, adding to Liquidia and Natera, trimming Lantheus and Tango Therapeutics, and selling out of Electronic Arts and CRNX.

Portfolio

2026 Q3, filed 11/16/2026, top 12 of 108 holdings

Top 5 31.0%, top 10 45.9%

AUM over time

2026 Q3 $23.2B +7.1% QoQ
2021 Q3: $19.7B 2021 Q3: $19.7B
Q3 2021
2021 Q4: $18.7B, −5.1% QoQ 2021 Q4: $18.7B, −5.1% QoQ
Q4
2022 Q1: $18.8B, +0.4% QoQ 2022 Q1: $18.8B, +0.4% QoQ
Q1 2022
2022 Q2: $16.3B, −13.7% QoQ 2022 Q2: $16.3B, −13.7% QoQ
Q2
2022 Q3: $16.8B, +3.5% QoQ 2022 Q3: $16.8B, +3.5% QoQ
Q3
2022 Q4: $15.3B, −9.3% QoQ 2022 Q4: $15.3B, −9.3% QoQ
Q4
2023 Q1: $17.7B, +15.8% QoQ 2023 Q1: $17.7B, +15.8% QoQ
Q1 2023
2023 Q2: $17.9B, +1.3% QoQ 2023 Q2: $17.9B, +1.3% QoQ
Q2
2023 Q3: $20B, +11.5% QoQ 2023 Q3: $20B, +11.5% QoQ
Q3
2023 Q4: $20.1B, +1.0% QoQ 2023 Q4: $20.1B, +1.0% QoQ
Q4
2024 Q1: $22.1B, +9.8% QoQ 2024 Q1: $22.1B, +9.8% QoQ
Q1 2024
2024 Q2: $21.2B, −4.2% QoQ 2024 Q2: $21.2B, −4.2% QoQ
Q2
2024 Q3: $20.4B, −3.6% QoQ 2024 Q3: $20.4B, −3.6% QoQ
Q3
2024 Q4: $19.7B, −3.5% QoQ 2024 Q4: $19.7B, −3.5% QoQ
Q4
2025 Q1: $17.9B, −9.0% QoQ 2025 Q1: $17.9B, −9.0% QoQ
Q1 2025
2025 Q2: $23.2B, +29.2% QoQ 2025 Q2: $23.2B, +29.2% QoQ
Q2
2025 Q3: $24.4B, +5.4% QoQ 2025 Q3: $24.4B, +5.4% QoQ
Q3
2025 Q4: $21.2B, −13.2% QoQ 2025 Q4: $21.2B, −13.2% QoQ
Q4
2026 Q1: $17.5B, −17.2% QoQ 2026 Q1: $17.5B, −17.2% QoQ
Q1 2026
2026 Q2: $21.7B, +23.6% QoQ 2026 Q2: $21.7B, +23.6% QoQ
Q2
2026 Q3: $23.2B, +7.1% QoQ 2026 Q3: $23.2B, +7.1% QoQ
Q3

Latest book

2026 Q3 2026 Q2, filed 6d ago, long equity only

RVMD, Revolution Medicines 11.87% Reduce −1.0% 13,418,796 $205.26 $2.8B −132,000 +$217M
WBD, Warner Bros. Discovery 6.58% New 49,372,344 $30.95 $1.5B +49,372,344 +$1.5B
NTRA, Natera 4.63%, was 2.78% Add +17.2% 2,599,648 $413.31 $1.1B +381,282 +$472M
BBIO, BridgeBio Pharma 4.04%, was 3.69% Add +32.6% 14,247,000 $65.80 $937M +3,503,937 +$137M
PTGX, Protagonist Therapeutics 3.91%, was 3.59% Add +1.4% 6,437,906 $140.89 $907M +89,000 +$129M
EXEL, Exelixis 3.70%, was 3.38% Add +9.1% 14,694,910 $58.41 $858M +1,226,900 +$126M
ROIV, Roivant Sciences 3.43%, was 2.34% Add +52.0% 21,745,533 $36.57 $795M +7,436,533 +$289M
ROKU, ROKU Inc 2.73% New 4,160,049 $152.28 $633M +4,160,049 +$633M
AMZN, Amazon 2.54%, was 2.90% Reduce −10.0% 2,368,464 $249.15 $590M −264,530 −$37M
GRAL, Grail 2.46% Reduce −2.2% 4,069,233 $140.12 $570M −92,351 +$286M
BSX, Boston Scientific 2.12%, was 2.07% Add +7.3% 11,287,164 $43.65 $493M +765,980 +$44M
AVGO, Broadcom 2.11%, was 2.01% Add +21.2% 1,395,810 $351.19 $490M +244,010 +$55M
CRH, CRH PLC 1.91% New 5,341,100 $82.80 $442M +5,341,100 +$442M
KVUE, Kenvue 1.90% New 25,015,000 $17.66 $442M +25,015,000 +$442M
TWST, Twist Bioscience 1.78% Hold 2,136,400 $193.24 $413M — —
UNH, UnitedHealth Group 1.66%, was 2.44% Reduce −17.5% 1,048,622 $367.08 $385M −221,910 −$143M
MSFT, Microsoft 1.62%, was 1.92% Reduce −34.1% 733,563 $512.90 $376M −379,300 −$39M
SNPS, Synopsys 1.61% Add +3.4% 857,890 $434.94 $373M +28,290 +$3.1M
KKR 1.53%, was 1.74% Reduce −5.8% 3,880,020 $91.30 $354M −238,280 −$24M
AON, Aon 1.48%, was 2.12% Reduce −10.3% 1,239,672 $276.77 $343M −142,890 −$115M
LNTH, Lantheus 1.33%, was 2.86% Reduce −44.3% 3,111,254 $99.53 $310M −2,472,225 −$310M
TMO, Thermo Fisher Scientific 1.30%, was 2.43% Reduce −57.5% 445,685 $675.05 $301M −603,500 −$225M
LQDA, Liquidia 1.16% Add +6.5% 8,906,038 $30.26 $269M +541,000 −$397M
WAB, Wabtec 1.09%, was 1.11% Reduce −1.9% 877,903 $287.18 $252M −16,600 +$11M
BEAM, Beam Therapeutics 1.08% Add +0.4% 10,276,396 $24.45 $251M +40,000 −$100M
ARMK, Aramark 1.06%, was 0.95% Add +27.0% 4,606,431 $53.55 $247M +980,700 +$40M
IMVT, Immunovant 0.94% Add +11.5% 6,471,000 $33.78 $219M +666,000 −$5.1M
AGIO, Agios Pharmaceuticals 0.85% Add +0.4% 5,939,400 $33.25 $197M +22,000 −$22M
BIIB, Biogen 0.66%, was 0.07% Add +859.0% 680,868 $225.88 $154M +609,868 +$138M
JNJ, Johnson & Johnson 0.55%, was 0.48% Add +17.8% 480,426 $264.74 $127M +72,426 +$24M
ACHC 0.55% Add +9.2% 4,608,400 $27.50 $127M +387,600 +$2.1M
BTSG, Brightspring Health Services 0.50% Add +17.9% 2,043,800 $56.75 $116M +311,000 −$4.9M
TNGX, Tango Therapeutics 0.49%, was 1.77% Reduce −62.9% 4,550,688 $24.95 $114M −7,726,312 −$270M
BIDU, Baidu 0.45% Hold 1,203,785 $86.87 $105M — —
AIG, American Savings Bank NA 0.35% New 4,557,082 $17.89 $82M +4,557,082 +$82M
PBLS, Parabilis Medicines 0.33% Hold 2,368,200 $32.29 $76M — —
AZN, AstraZeneca 0.31%, was 0.50% Reduce −23.3% 440,000 $161.47 $71M −134,000 −$38M
JOYY 0.28%, was 0.21% Add +17.3% 820,200 $80.25 $66M +121,000 +$20M
AVTX, Avalo Therapeutics 0.26%, was 0.21% Add +59.1% 3,974,000 $15.33 $61M +1,476,000 +$15M
FRNM, Freenome 0.25% New 3,733,757 $15.75 $59M +3,733,757 +$59M
IOND, Ionic Digital 0.25% New 718,123 $80.33 $58M +718,123 +$58M
GH, Guardant Health 0.21%, was 0.22% Reduce −13.2% 279,700 $178.36 $50M −42,500 +$1.5M
ASMB, Assembly Biosciences 0.16% Hold 1,604,590 $23.49 $38M — —
NVS, Novartis 0.16%, was 0.26% Reduce −29.8% 255,000 $142.57 $36M −108,000 −$21M
MAZE, Maze Therapeutics 0.13% Hold 1,107,814 $27.18 $30M — —
LBRX, LB Pharmaceuticals 0.12% New 741,410 $38.38 $28M +741,410 +$28M
Immunocore 0.12% New 928,000 $30.29 $28M +928,000 +$28M
ASML 0.11% New 13,518 $1,812 $24M +13,518 +$24M
RIO, Rio Tinto 0.09%, was 0.08% Add +19.3% 218,899 $94.17 $21M +35,424 +$3.2M
BABA, Alibaba 0.09% New 189,000 $107.54 $20M +189,000 +$20M

Showing top 50 of 108 by value

Exits / last held

Gone since 2026 Q2, shown at their last reported size.

Stock % of portfolio Recent activity Shares Reported price* Value Share change $ change
EA, Electronic Arts 7.49% Exit 0 $205.04 $1.6B −7,919,500 −$1.6B
CRNX 1.55% Exit 0 $37.42 $336M −8,989,098 −$336M
NVO, Novo Nordisk 0.58% Exit 0 $47.94 $126M −2,619,000 −$126M
MRK, Merck 0.12% Exit 0 $128.50 $26M −199,000 −$26M
WRBY, Warby Parker 0.12% Exit 0 $30.34 $25M −828,000 −$25M
PCSC, Perceptive Cap Solutions 0.11% Exit 0 $10.88 $24M −2,250,000 −$24M
AXTA, Axalta Coating Systems 0.08% Exit 0 $34.22 $16M −478,000 −$16M
BBNX, Beta Bionics 0.04% Exit 0 $15.67 $9.3M −595,000 −$9.3M
SMG, Scotts Miracle-Gro 0.03% Exit 0 $68.11 $6M −88,000 −$6M
WAY, Waystar 0.03% Exit 0 $20.53 $5.4M −264,900 −$5.4M
BC, Brunswick 0.02% Exit 0 $84.25 $5.1M −61,000 −$5.1M
GNTX, Gentex 0.02% Exit 0 $25.27 $5M −199,000 −$5M
IDXX, Idexx Laboratories 0.02% Exit 0 $526.44 $4.7M −9,000 −$4.7M
CMC, Commercial Metals 0.02% Exit 0 $62.75 $4.2M −67,000 −$4.2M
TEVA, Teva Pharmaceutical Industries 0.01% Exit 0 $33.88 $1.4M −40,000 −$1.4M
ANNA, Aleanna — Exit 0 $2.90 $227K −78,400 −$227K
BYND, Beyond Meat — Exit 0 $0.7368 $14K −19,000 −$14K

Weight bar: held both quarters added sold at this quarter’s reported price

* Reported price is value ÷ shares from the 13F as of period end, not a live market quote. Weight % is each long-equity position ÷ full 13F AUM, so rows may not sum to 100% when the filing includes options or other non-equity (excluded from this table). Share change and $ change are vs 2026 Q2. Click a column header to sort, or New, Hold, Add or Reduce to bring those moves to the top. Exit opens the last-held block below.

Filings history

21 periods, with AUM normalized

Period Holds AUM QoQ Form Filed Filing ID
2026 Q3 116 $23.2B +7.1% 13F-HR 11/16/2026 000090883426000540
2026 Q2 3 $1.4B — new holds 11/16/2026 000090883426000544
2026 Q2 89 $21.7B +23.6% 13F-HR 8/14/2026 000090883426000432
2026 Q1 2 $1.4B — new holds 11/16/2026 000090883426000542
2026 Q1 1 $1.5B — new holds 8/14/2026 000090883426000434
2026 Q1 172 $17.5B −17.2% 13F-HR 5/15/2026 000090883426000240
2025 Q4 2 $1B — new holds 11/16/2026 000090883426000546
2025 Q4 1 $1B — new holds 8/14/2026 000090883426000433
2025 Q4 2 $884M — new holds 5/15/2026 000090883426000241
2025 Q4 151 $21.2B −13.2% 13F-HR 2/17/2026 000090883426000087
2025 Q3 144 $24.4B — RESTATEMENT 2/17/2026 000090883426000086
2025 Q3 144 $24.4B +5.4% 13F-HR 11/14/2025 000090883425000353
2025 Q2 1 $140M — new holds 2/17/2026 000090883426000085
2025 Q2 3 $483M — new holds 11/14/2025 000090883425000352
2025 Q2 141 $23.2B +29.2% 13F-HR 8/14/2025 000090883425000248
2025 Q1 1 $274M — new holds 2/17/2026 000090883426000084
2025 Q1 3 $416M — new holds 11/14/2025 000090883425000351
2025 Q1 7 $2.2B — new holds 8/14/2025 000090883425000247
2025 Q1 135 $17.9B −9.0% 13F-HR 5/15/2025 000090883425000177
2024 Q4 1 $85M — new holds 2/17/2026 000090883426000083
2024 Q4 2 $349M — new holds 11/14/2025 000090883425000350
2024 Q4 6 $2.3B — new holds 8/14/2025 000090883425000246
2024 Q4 4 $333M — new holds 5/15/2025 000090883425000180
2024 Q4 138 $19.7B −3.5% 13F-HR 2/14/2025 000090883425000081
2024 Q3 1 $145M — new holds 11/14/2025 000090883425000349
2024 Q3 6 $1.5B — new holds 8/14/2025 000090883425000243
2024 Q3 3 $216M — new holds 5/15/2025 000090883425000179
2024 Q3 2 $544M — new holds 2/14/2025 000090883425000080
2024 Q3 153 $20.4B −3.6% 13F-HR 11/14/2024 000090883424000307
2024 Q2 1 $120M — new holds 11/14/2025 000090883425000348
2024 Q2 5 $1.2B — new holds 8/14/2025 000090883425000245
2024 Q2 1 $199M — new holds 5/15/2025 000090883425000178
2024 Q2 2 $452M — new holds 2/14/2025 000090883425000079
2024 Q2 1 $149M — new holds 11/14/2024 000090883424000324
2024 Q2 157 $21.2B −4.2% 13F-HR 8/14/2024 000090883424000200
2024 Q1 1 $93M — new holds 11/14/2025 000090883425000347
2024 Q1 4 $1.2B — new holds 8/14/2025 000090883425000244
2024 Q1 2 $159M — new holds 2/14/2025 000090883425000078
2024 Q1 1 $45M — new holds 8/14/2024 000090883424000202
2024 Q1 167 $22.1B — RESTATEMENT 5/24/2024 000090883424000159
2024 Q1 167 $22.1B +9.8% 13F-HR 5/15/2024 000090883424000135
2023 Q4 1 $65M — new holds 11/14/2025 000090883425000346
2023 Q4 2 $548M — new holds 8/14/2025 000090883425000250
2023 Q4 5 $1.1B — new holds 5/15/2024 000090883424000141
2023 Q4 150 $20.1B +1.0% 13F-HR 2/14/2024 000090883424000070
2023 Q3 1 $40M — new holds 11/14/2025 000090883425000345
2023 Q3 1 $40M — new holds 5/15/2024 000090883424000138
2023 Q3 2 $1.4B — new holds 2/14/2024 000090883424000077
2023 Q3 1 $1.9B — new holds 2/12/2024 000090883424000049
2023 Q3 159 $20B +11.5% 13F-HR 11/14/2023 000090883423000150
2023 Q2 2 $669M — new holds 2/14/2024 000090883424000076
2023 Q2 5 $1.4B — new holds 11/14/2023 000090883423000157
2023 Q2 1 $1.2B — new holds 10/26/2023 000090883423000134
2023 Q2 165 $17.9B +1.3% 13F-HR 8/14/2023 000090883423000109
2023 Q1 2 $234M — new holds 2/14/2024 000090883424000075
2023 Q1 3 $389M — new holds 11/14/2023 000090883423000156
2023 Q1 1 $15M — new holds 8/14/2023 000090883423000110
2023 Q1 187 $17.7B +15.8% 13F-HR 5/15/2023 000117570723000127
2022 Q4 1 $171M — new holds 2/14/2024 000090883424000074
2022 Q4 3 $485M — new holds 11/14/2023 000090883423000155
2022 Q4 7 $1B — new holds 5/15/2023 000117570723000136
2022 Q4 232 $15.3B −9.3% 13F-HR 2/14/2023 000117570723000051
2022 Q3 1 $125M — new holds 2/14/2024 000090883424000073
2022 Q3 3 $415M — new holds 11/14/2023 000090883423000154
2022 Q3 5 $411M — new holds 5/15/2023 000117570723000135
2022 Q3 4 $434M — new holds 2/14/2023 000090966123000005
2022 Q3 298 $16.8B +3.5% 13F-HR 11/14/2022 000156761922019851
2022 Q2 1 $115M — new holds 2/14/2024 000090883424000081
2022 Q2 3 $411M — new holds 11/14/2023 000090883423000153
2022 Q2 2 $337M — new holds 5/15/2023 000117570723000134
2022 Q2 3 $136M — new holds 2/14/2023 000090966123000003
2022 Q2 9 $1.2B — new holds 11/14/2022 000156761922019862
2022 Q2 297 $16.3B −13.7% 13F-HR 8/15/2022 000156761922015953
2022 Q1 1 $268M — new holds 11/14/2023 000090883423000152
2022 Q1 1 $314M — new holds 5/15/2023 000117570723000133
2022 Q1 1 $27M — new holds 2/14/2023 000090966123000002
2022 Q1 3 $186M — new holds 11/14/2022 000156761922019864
2022 Q1 8 $1.1B — new holds 8/15/2022 000156761922015972
2022 Q1 307 $18.8B +0.4% 13F-HR 5/16/2022 000156761922010736
2021 Q4 1 $227M — new holds 5/15/2023 000117570723000132
2021 Q4 1 $7M — new holds 11/14/2022 000156761922019852
2021 Q4 1 $115M — new holds 8/15/2022 000156761922015968
2021 Q4 2 $98M — new holds 5/19/2022 000156761922011257
2021 Q4 6 $833M — new holds 5/16/2022 000156761922010757
2021 Q4 289 $18.7B −5.1% 13F-HR 2/14/2022 000156761922003965
2021 Q3 1 $182M — new holds 5/15/2023 000117570723000131
2021 Q3 1 $105M — new holds 8/15/2022 000156761922015964
2021 Q3 1 $57M — new holds 5/19/2022 000156761922011256
2021 Q3 3 $998M — new holds 5/16/2022 000156761922010753
2021 Q3 2 $344M — new holds 2/14/2022 000156761922003981
2021 Q3 293 $19.7B — 13F-HR 11/15/2021 000095012321015168

About

Farallon Capital Management, L.L.C.

91 processed 13Fs on this site, 2021 Q3 to 2026 Q3

SEC filing name
FARALLON CAPITAL MANAGEMENT, L.L.C.
Location
San Francisco, CA
All SEC filings
View on sec.gov

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

  • The Essays of Warren Buffett, 8th Ed., Warren Buffett, Lawrence A. Cunningham View on Amazon
  • One Up On Wall Street (Lynch), Peter Lynch View on Amazon

More on the shelf